Randal Henderson Awarded National Cancer Institute Subcontract

Dr. Randal Henderson, a Professor at the Department of Radiation Oncology at the University of Florida (UF) and the Associate Medical Director at the UF Health Proton Therapy Institute, will be leading a collaborative project with DiaCarta, Inc., titled “RadTox: Measuring Radiation Toxicity using Circulating DNA.”

This collaborative program between the Department of Radiation Oncology at UF, the UF Health Proton Therapy Institute, and Diacarta will be funded by a Small Business Innovation Research contract awarded to DiaCarta by the National Cancer Institute.

Together, they hope to convert RadTox QuantiDNATM into a cutting-edge test that monitors radiation response in cancer patients using blood specimens from patients undergoing radiotherapy for prostate cancer.

To find out more information about the RADTOX project, click here.

Nationally ranked

U.S. News and World Report

Nationally ranked in 6 adult specialties and 6 pediatric specialties and rated high performing in 4 adult specialties and 5 procedures and conditions.


defining optimal treatments

Annual Research Seminar

The seminar has three concurrent programs for radiation therapy, oncology nursing, and radiation oncology.



UF Health Cancer Center

Our Mission is to prevent, detect, treat and ultimately cure cancer while addressing the unique challenges of the cancer burden faced by the population we serve.

UF Health Cancer Center